Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Santen Pharm CO ADR (OP:SNPHY)

11.78 -0.07 (-0.59%)
Streaming Delayed Price Updated: 10:42 AM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Santen Pharm CO ADR

News headline image
Santen Joins Inaugural Global Summit for Eye Health as High-Impact Partner
From Santen Pharmaceutical Co., Ltd.
Via JCN Newswire
News headline image
SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023 ↗
Santen Pharmaceutical just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Current Analysis: Santen Pharmaceutical ↗
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market... 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.